We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

15 hedge funds and large institutions have $1.14M invested in Sonoma Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

356% more capital inflows, than outflows

Capital inflows: $128K | Capital outflows: $28K

25% more funds holding

Funds holding: 12 → 15 (+3)

1.39% less ownership

Funds ownership: 4.28% → 2.89% (-1.4%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
B. Riley Wealth Advisors
B. Riley Wealth Advisors
Florida
+$73.2K
2
Virtu KCG Holdings
Virtu KCG Holdings
New York
+$34.3K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$4.67K
4
Johnson Financial Group Inc (Wisconsin)
Johnson Financial Group Inc (Wisconsin)
Wisconsin
+$3.12K
5
Morgan Stanley
Morgan Stanley
New York
+$3.12K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$28K

SNOA Hedge Fund Activity: Q4 2014 in Review

15 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2014, worth a combined $1.14M — up 31% from $870K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SNOA positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was B. Riley Wealth Advisors, adding an estimated $73.2K. The largest seller was Jane Street, exiting entirely with an estimated $28K sold.

  • 15 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2014, up from 12 in Q3 2014.
  • Funds reported $1.14M of Sonoma Pharmaceuticals stock for Q4 2014, up 31% quarter-over-quarter.
  • 5 funds opened new Sonoma Pharmaceuticals positions in Q4 2014 and 1 closed out, a net change of +4 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q4 2014 was B. Riley Wealth Advisors, an estimated $73.2K added.
  • The largest Sonoma Pharmaceuticals seller in Q4 2014 was Jane Street, an estimated $28K sold.

Based on aggregated 13F filings for Q4 2014.